NIO im Marii Sklodowskiej-Curie

Warsaw 02-034

0 studies enrolling now · 2 studies all time

What they study most

Esophageal Squamous Cell Carcinoma, Hepatocellular Carcinoma

Studies at this site

• A Study of Atezolizumab With or Without Tiragolumab in Participants With Unresectable Esophageal Squamous Cell Carcinoma Whose Cancers Have Not Progressed Following Definitive Concurrent Chemoradiotherapy — Running, not enrolling
• A Study Evaluating Atezolizumab and Bevacizumab, With or Without Tiragolumab, in Participants With Untreated Locally Advanced or Metastatic Hepatocellular Carcinoma (HCC) (IMbrave152) — Running, not enrolling